Isatin 1,2,3-triazoles as potent inhibitors against caspase-3

Sixteen disubstituted 1,2,3-triazoles were prepared using the Huisgen cycloaddition reaction and evaluated as inhibitors against caspase-3. The two most potent inhibitors were found to be (S)-1-((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-5-((2-(methoxymethyl)pyrrolidin-1-yl)sulfonyl)indoline-2,3-dione (7f) and (S)-1-((1-benzyl-1H-1,2,3-triazol-5-yl)methyl)-5-((2-(methoxymethyl)pyrrolidin-1-yl)sulfonyl)indoline-2,3-dione (8g) with IC₅₀-values of 17 and 9 nM, respectively. Lineweaver-Burk plots revealed that these two triazoles show competitive inhibitory mechanism against caspase-3.     

Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities

A series of two classes of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates were synthesized using click chemistry approach. All compounds were evaluated for inhibition of Src kinase and human ovarian adenocarcinoma (SK-Ov-3), breast carcinoma (MDA-MB-361), and colon adenocarcinoma (HT-29). Hexyl triazolyl-substituted 3-phenylpyrazolopyrimidine exhibited inhibition of Src kinase with an IC₅₀ value of 5.6 μM. 4-Methoxyphenyl triazolyl-substituted 3-phenylpyrazolopyrimidine inhibited the cell proliferation of HT-29 and SK-Ov-3 by 73% and 58%, respectively, at a concentration of 50 μM.     

Phosphane- and phosphite-silver(I) phenolates: Synthesis, characterization and their use as CVD precursors

The silver(I) salts [AgOR] (3a, R = C₉H₆N; 3b, R = C₆H₄-2-CHO, 3c, R = C₆H₄-2-Cl; 3d, R = C₆H₄-2-CN; 3e, R = C₆H₄-2-NO₂) are accessible by the stoichiometric reaction of [AgNO₃] (1) with HOR (2a, R = C₉H₆N; 2b, R = C₆H₄-2-CHO; 2c, R = C₆H₄-2-Cl; 2d, R = C₆H₄-2-CN; 2e, R = C₆H₄-2-NO₂) in presence of NEt₃. Treatment of 3a-3e with PⁿBu₃ (4), P(OMe)₃ (5a) or P(OCH₂CF₃)₃ (5b) in the ratios of 1:1 and 1:2, respectively, produced complexes [L_mAgOR] (L = PⁿBu₃, m = 1: 6a, R = C₉H₆N; 6b, R = C₆H₄-2-CHO; 6c, R = C₆H₄-2-Cl; 6d, R = C₆H₄-2-CN; 6e, R = C₆H₄-2-NO₂. m = 2: 7a, R = C₉H₄; 7b, R = C₆H₄-2-CHO; 7c, R = C₆H₄-2-Cl; 7d, R = C₆H₄-2-CN; 7e, R = C₆H₄-2-NO₂. L = P(OMe)₃, m = 1: 8a, R = C₆H₄-2-CHO; 8b, R = C₆H₄-2-NO₂. m = 2: 9, R = C₆H₄-2-NO₂. L = P(OCH₂CF₃)₃, m = 1: 10, R = C₆H₄-2-NO₂). Based on TGA, temperature-programmed and in situ molecular beam mass spectrometry metal-organic 7e was applied as CVD precursor in the deposition of silver onto glass substrates. The resulting silver films were characterized by XRD. The SEM image of a film grown from 7e at 350 °C showed a homogeneous surface with grain sizes of 40 nm. The molecular structures of 8b and 10 in the solid state were determined. They are isostructural and are cubane-like structured. Low-temperature ³¹P{¹H} NMR studies showed that the title complexes are dynamic in solution and exchange at room temperature their ligands.     

Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1

The synthesis, cytotoxicity, inhibition of tubulin polymerization data and anti-angiogenetic effects of seven 1,5-disubstituted 1,2,3-triazole analogs and two 1,4-disubstituted 1,2,3-triazole analogs of combretastatin A-1 (1) are reported herein. The biological studies revealed that the 1,5-disubstituted 1,2,3-triazoles 3-methoxy-6-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-5-yl)benzene-1,2-diol (6), 3-methoxy-6-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-5-yl)benzene-1,2-diamine (8) and 5-(2,3-difluoro-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole (9) were the three most active compounds regarding inhibition of both tubulin polymerization and angiogenesis. Molecular modeling studies revealed that combretastatins 1 and 2 and analogs 5-11 could be successfully docked into the colchicine binding site of α,β-tubulin.     

Synthesis,characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells

Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) is essential for physiological functions of tissues and neovasculature. VEGFR signaling is associated with the progression of pathological angiogenesis in various types of malignancies, making it an attractive therapeutic target in cancer treatment. In the present work, we report the synthesis of 1,4-disubstituted 1,2,3-triazoles and 1,2,4-triazolo[1, 5-a]pyrimidine derivatives via copper (I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction and screened for their anticancer activity against MCF7 cells. We identified 1-(2′-ethoxy-4′-fluoro-[1,1′-biphenyl]-4-yl)-4-phenyl-1H-1,2,3-triazole (EFT) as lead cytotoxic agent against MCF7 cell lines with an IC₅₀ value of 1.69?µM. Further evaluation revealed that EFT induces cytotoxicity on Ishikawa, MDA-MB-231 and BT474 cells with IC₅₀ values of 1.97, 4.81 and 4.08?µM respectively. However, EFT did not induce cytotoxicity in normal lung epithelial (BEAS-2B) cells. Previous reports suggested that 1,2,3-triazoles are the inhibitors of VEGFR1 and therefore, we evaluated the effect of EFT on the expression of VEGFR1. The results demonstrated that EFT downregulates the expression of VEGFR1 in MCF7 cells. In summary, we identified a potent cytotoxic agent that imparts its antiproliferative activity by targeting VEGFR1 in breast cancer cells. The novel compound could serve as a lead structure in developing VEGFR1 inhibitors.     

Highly trans-1,4 selective polymerization of 1,3-butadiene initiated by iron(III) bis(imino)pyridyl complexes

A series of 2,6-bis(imino)pyridyl iron(III) complexes of the general formula [2,6-(ArNCMe)₂C₅H₃N]FeCl₃ (Ar = -C₆H₅, 3a; 2-MeC₆H₄, 3b; 2-EtC₆H₄, 3c; 2-ⁱPrC₆H₄, 3d; cyclohexyl, 3e; 4-MeC₆H₄, 3f; 4-ⁱPrC₆H₄, 3g; 4-FC₆H₄, 3h and 4-CF₃C₆H₄, 3i), activated by alkylaluminum, MAO or MMAO, have been investigated in 1,3-butadiene polymerization. Iron(III) complex (3a), with the least steric hindrance around the metal center, gives polymer up to 99% in yield in 4 h (butadiene to iron ratio = 1000), and trans-1,4 selectivity about 94.7% at room temperature in toluene, while those (3b-3d) bearing alkyl substituents at the 2-position of each N-aryl ring exhibit much lower catalytic activity and tunable trans-1,4 selectivity. Introduction of an alkyl group at the 4-position (para-position, 3f and 3g) exerts a slightly beneficial effect on the trans-1,4 selectivity, while electronegative groups at the same position (3h and 3i) affect negatively on the activity. The effects of temperature, types of cocatalyst and Al/Fe molar ratio on the polymerization behavior are investigated. More importantly, a mechanism for forming trans-1,4 structure is also proposed.     

The synthesis of triethylphosphine gold(I) 4-nitrobenzenethiolate and solvent dependent visible absorption spectra of 4-nitrobenzenethiolate

The synthesis of triethylphosphine gold(I) 4-nitrobenzenethiolate, Et₃PAu(SC₆H₄NO₂-4), is reported. Et₃PAu(SC₆H₄NO₂-4) displays a low energy visible electronic absorption band which is solvent dependent: EtOH (λ_max = 385 nm), acetonitrile (λ_max = 391 nm), THF (λ_max = 395 nm), and DMSO (λ_max = 402 nm). The corresponding low energy visible electronic absorption band of 4-nitrobenzenethiolate, 4-NO₂C₆H₄S⁻ also shows solvent dependency: acetonitrile, (λ_max = 484 nm), DMSO (λ_max = 502 nm), dimethylformamide (λ_max = 505 nm). The positive solvatochromic shifts for Et₃PAu(SC₆H₄NO₂-4) and 4-NO₂C₆H₄S⁻ are consistent with an intraligand (IL) charge transfer transition, i.e. π(S) → ∗π (C₆H₄NO₂-4) or n(S) → ∗π (C₆H₄NO₂-4). Assignment of 4-NO₂C₆H₄S⁻ was aided by a DFT calculation.     

Reactions of ketones with coordinated nitriles on β-diketonato ruthenium complexes leading to formation of compounds with new carbon-carbon bonds

The reactions of [Ru(acac)₂(CH₃CN)₂] with four ketones (acetone, ethyl methyl ketone, acetylacetone and monochloroacetone), and the reactions of [Ru(acac)₂(C₆H₅CN)₂] with two ketones (acetone and ethyl methyl ketone) yielded six novel compounds of β-ketiminato ruthenium complexes: [Ru(acac)₂(mhmk)], [Ru(acac)₂(ehmk)], [Ru(acac)₂(mAmk)], [Ru(acac)₂(mClmk)], Ru(acac)₂(mhbk)], and [Ru(acac)₂(ehbk)] (mhmk = 4-iminopentane-2-one mono anion, ehmk = 5-iminohexane-3-one mono anion, mAmk = 3-(1-iminoethyl)-2,4-pentanedione mono anion, mClmk = 3-chloro-4-imino-pentane-2-one mono anion, mhbk = 1-phenyl-1-iminobutane-3-one mono anion, ehbk = 1-phenyl-1-iminopentane-3-one mono anion). All the new complexes have been characterized by elemental analyses, ¹H NMR, MS and electronic spectral data. Crystal and molecular structures for the six β-ketimine complexes have been solved by single crystal X-ray diffraction studies. A mechanism involving the attack of ketones on the coordinated nitrile has been proposed. The electrochemical redox behavior of the β-ketimine complexes has been elucidated.     

Synthesis, structures and luminescent behaviour of tridentate salicylaldiminato-type borate complexes

Treatment of the ligands 3,5-tBu₂-2-(OH)C₆H₂CHNR [R = 2-(CO₂H)C₆H₄ (1a) and 2-(CO₂H)C₁₀H₆ (1b)] with trimethylborate, B(OMe)₃, in toluene yields, after work-up, the yellow crystalline complexes {[3,5-tBu₂-2-(O)C₆H₂CHNR]B(OMe)} [R = 2-(CO₂)C₆H₄ (2a) and 2-(CO₂)C₁₀H₆ (2b)], respectively. Further treatment of these complexes with trifluoromethanesulfonic (triflic) acid, CF₃SO₃H, followed by recrystallisation from tetrahydrofuran (thf) afforded the triflate salts [{3,5-tBu₂-2-(O)C₆H₂CHNR}B(thf)][CF₃SO₃] [R = 2-(CO₂)C₆H₄ (3a) and 2-(CO₂)C₁₀H₆ (3b)]. An electroluminescent device was constructed using 2a, which produced orange-green light with broad emission spectra (maximum brightness of 5 cd/m² being observed at 13 V). Compounds 1a and 2b·2MeCN have been characterised by single crystal X-ray structure determinations.     

Synthesis, isolation and spectroscopic characterization of Dawson polyoxotungstate-supported, organometallic complex, [{(C6H6)Ru}P2W15V3O62]: The two positional isomers

The Dawson polyoxotungstate (POM)-based, organometallic ruthenium(II) complex, [{(C₆H₆)Ru}P₂W₁₅V₃O₆₂]⁷⁻, was synthesized as two materials, i.e. 1 · 2Bu₄NCl and 1 · 1Bu₄NCl (1 = (Bu₄N)₇[{(C₆H₆)Ru}P₂W₁₅V₃O₆₂]), which contained two positional isomers a and b as major or minor species. In isomer a with the overall C_s symmetry, the (C₆H₆)Ru²⁺ group was supported on one vanadium(V) octahedral site (two V-O-V bridging oxygens and one OV terminal oxygen) of the three edge-shared vanadium(V) octahedra (V₃ site, B-site) in the Dawson POM-support [1,2,3-P₂W₁₅V₃O₆₂]⁹⁻, whereas in the other isomer b with the overall C_3v symmetry, the (C₆H₆)Ru²⁺ group was supported on the center of the V₃ site in the Dawson POM-support. Material 1 · 2Bu₄NCl was prepared by a stoichiometric reaction in CH₂Cl₂ at ambient temperature of the Dawson POM-support (Bu₄N)₉[1,2,3-P₂W₁₅V₃O₆₂] with the precursor [(C₆H₆)RuCl₂]₂, whereas material 1 · 1Bu₄NCl was prepared by a stoichiometric reaction in CH₃CN under refluxing conditions. The temperature-varied ³¹P NMR spectra revealed that b was thermodynamically more stable thana.     

Synthesis and biological evaluation of 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles as transforming growth factor-β type 1 receptor kinase inhibitors

A series of 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles has been synthesized and evaluated for their ALK5 inhibitory activity. The 1-(6-methylpyridin-2-yl)-1,2,3-triazoles were assembled by Cu(I)-catalyzed azide–alkyne 1,3-dipolar cycloaddition. Following this, quinoxaline was introduced through Pd-catalyzed direct arylation. The synthesized 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles revealed significant selectivity differences with respect to p38α MAP kinase. In particular, 12k showed 80.8% ALK5 inhibitory activity at a concentration of 10 μM and IC₅₀ value of 4.69 μM, but did not show p38α MAP kinase inhibitory activity (?1.94% inhibition at a concentration of 10 μM).     

New chelate complexes of trivalent Y and lanthanides (Eu, Ho, Yb) with a triazene N-oxide: Synthesis, structural characterization and luminescence properties

Deprotonated 3-(4-nitrophenyl)-1-phenyltriazene N-oxide reacts with YCl₃·6H₂O and LnCl₃·6H₂O (Ln = Eu, Ho, Yb) to give the monoclinic chelate complexes [Y{O₂N(C₆H₄)NNN(O)Ph}₄](Et₃NH)·H₂O (1) (Ph = C₆H₅; Et = C₂H₅) and [Ln^III{O₂N(C₆H₄)NNN(O)Ph}₄](Et₃NH)·H₂O·{CH₃OH∗} {Ln^III = Eu (2), Ho (3), Yb∗ (4), in which the metal centers present a square antiprismatic configuration. As already observed for hydrated ammonium complexes of triazene-oxides ligands with (C₆H₄)−NO₂ groups, multiple, effective O···H and N···H interactions hold the species in supramolecular 3D assemblies. The optical and the luminescent properties of the triazene-oxide europium complex 2 are also presented and fully discussed.     

Part II. Chiral dirhodium (II) catalysts with ortho-metalated arylphosphane ligands in the enantioselective intramolecular cyclopropanation of a racemic α-diazo ketone

In this report, chiral dirhodium (II) with ortho-metalated phosphane ligands, namely (M)-Rh₂(O₂CR) ₂(PC)₂ [PC = ortho-metalated aryl phosphane, O₂CR = carboxylate bridging ligands) (1a-g), have been used for the intramolecular cyclopropanation of racemic1-diazo-6-methyl-3-(2-propenyl)-5-hepten-2-one (2), containing both a tri- and monosubstituted carbon-carbon double bond, in pentane. The highest level of regiocontrol has been obtained with chiral catalyst Rh₂(O₂CCH₃)₂[(p-MeC₆H₃)P(p-MeC₆H₄)₂]₂ (M)-1c, affording favorably trisubstituted cyclopropane 3 versus monosubstituted cyclopropane 4 in 74:26 ratio. An exceptional diastereoselectivity was obtained with the entire catalyst series, leading to the unique formation of the syn products. Excellent enantiocontrol values (80-90% ee) have been achieved with catalysts 1a [(PC = (C₆H₃)P(C₆H₄)₂, R = C(CH₃)₃)], 1c [PC = p-MeC₆H₃)P(p-MeC₆H₄)₂, R = CH₃], 1f [PC = m-CH₃C₆H₃)P(m-CH₃C₆H₄)₂, R = CF₃] and 1g [PC = 3,5-(CH₃)₂C₆H₃)P(3,5-(CH₃)₂C₆H₄)₂, R = CF₃] at room temperature. Pentane is found to be a convenient solvent for high enantiocontrol in the cyclopropanation of α-diazo ketone 2.     

Synthesis and theoretical analysis of the structures and bonding in five new neutral square planar bis[2,4-di(aryl)-1,3,5-triazapentadienato]nickel(II) complexes

Solvothermal reactions in methanol of nickel acetate tetrahydrate, Ni(OAc)₂ · 4H₂O, with benzonitrile derivatives NC(C₆H₄)X, where X is one of the electron withdrawing substituents -CN, -NO₂, or -CF₃, located at the m- or p-positions relative to -CN, yield complexes of the general formula Ni{HNC(R)-NC(R)-NH}₂. More specifically, 3-nitrobenzonitrile, 4-nitrobenzonitrile, 1,3-dicyanobenzene, 1,4-dicyanobenzene, and ααα-trifluoro-p-toluonitrile are found to react with Ni(OAc)₂ · 4H₂O to yield Ni{HNC(R)-NC(R)-NH}₂, where R = 3-(NO₂)C₆H₄, 4-(NO₂)C₆H₄, 3-(CN)C₆H₄, 4-(CN)C₆H₄, or 4-(CF₃)C₆H₄, respectively. Analogous reactions of nitriles lacking electron withdrawing groups do not occur under similar conditions. Solid-state structures have been determined for the complexes with p-NO₂, p-CN, and p-CF₃ substituents on the phenyl rings. In addition, we describe density functional theory (DFT) and natural bonding orbital theory (NBO) studies on a simplified analog of these compounds, aimed at understanding their molecular bonding. It is shown that the new compounds for which solid-state structures have been determined are model examples of coordination compounds containing robust ω-bonds.     

Stereochemistry of the reaction products of the oxidative addition reaction of methyl iodide to [Rh((C4H3S)COCHCOR)(CO)(PPh3)]: A NMR and computational study. R = CF3, C6H5, C4H3S

A NMR study of the reaction mixture of the square planar [Rh((C₄H₃S)COCHCOR)(CO)(PPh₃)] complex and CH₃I, where R = CF₃, C₆H₅ or C₄H₃S, revealed that two types of alkyl and one (R = CF₃) or two (R = C₆H₅ or C₄H₃S) types of acyl species exist in the system. Two isomers of each species with an unsymmetrical β-diketonato ligand were observed. ¹H-¹H NOESY NMR unambiguously showed that the PPh₃ group is in the apical position in the more stable Rh^III-alkyl product. Theoretical computations of the equilibrium geometry of the possible reaction products, consistent with experimental observations, revealed that the first alkyl product results from trans addition to Rh^I and that the second thermodynamic alkyl product adopts an octahedral geometry with the PPh₃ group and the iodide above and below the square planar plane. Theoretical computations also revealed that the thermodynamic acyl product adopts a square-pyramidal geometry with the COCH₃ group in the apical position.     

Binuclear cyclopalladated pincer compounds bridged by ditopic nitrogenated ligands

The binuclear cyclopalladated compounds [(SCS)Pd-pz-Pd(SCS)][BF₄]₂ (pz = pyrazine) 2a, [(SCS)Pd-bipy-Pd(SCS)][BF₄]₂ (bipy = 4,4′-bipyridine) 2b, [(SCS)Pd-dcb-Pd(SCS)][BF₄]₂ (dcb = 1,4-dicyanobenzene) 2c and [(SCS)Pd-tmeda-Pd(SCS)][BF₄]₂ (tmeda = N,N,N′,N′-tetramethylethylenediamine) 2d (SCS = {C₆H₃-2,6-(CH₂SC₆H₄F-4)₂}) were synthesized by a substitution reaction between the pincer unit [Pd(C₆H₃-2,6-(CH₂SC₆H₄F-4)₂)Cl] 1 and the corresponding bidentate nitrogenated ligands. The topology of the bridging ligand between both pincer units induces the aggregation of the organometallic cations in the solid state. The X-ray diffraction molecular structures of complexes 2a and 2d are also reported.     

Synthesis, crystal structures, and fluorescence properties of six complexes with thiophene derivative carboxylic acid ligand

The crystallization of 2,3-dihydro-thieno[3,4-b][1,4] dioxine-5,7-dicarboxylic acid (H₂tddc) with divalent transitional metal (Co, Ni, Zn, Cd) or with tervalent lanthanide metal (Sm) and with mixed ligand 4,4′-bipyridine (4,4′-bipy) or 1,10-phenanthroline (1,10-phen) formed six new complexes: [Co(C₈H₄O₆S) · 3H₂O] (1), [Co(C₈H₄O₆)(1,10-phen)(H₂O)] · H₂O (2), [Ni(C₈H₄O₆S)(4,4′-bipy)(H₂O)] · 3H₂O (3) [Sm(C₈H₄O₆S)(NO₃)(H₂O)₄] · 2H₂O (4), [Zn(C₈H₄O₆S)(H₂O)₃] (5), and [Cd₂(C₈H₄O₆S)₂(4,4′-bipy)₂] (6). The structures of these six crystals have been characterized by single-crystal X-ray diffraction analyses, which revealed that complexes 1, 4, 5 are all one-dimensional chain structures and they self-assemble into three-dimensional super-molecules via the hydrogen bond interactions and π-π stacking interactions, 2 is also a one-dimensional chain structure but still self-assembles into one-dimensional double-chains, the complex 3 has two-dimensional undulating parallelogram grid structure extended along the bc-plane, the crystal of 6 is a 3D threefold interpenetration topology framework with 4⁶6³8 nodes. The photoluminescent properties of the H₂tddc ligand and the six compounds have been measured in the solid state at room temperature. Free ligand has no luminescence, while its complexes 1, 4, and 6 all exhibit intense photoluminescence which implies that these complexes may be excellent candidates for potential photoactive materials.     

Synthesis,antitumor activity,and cytotoxicity of 4-substituted 1-benzyl-5-diphenylstibano-1H-1,2,3-triazoles

Trisubstituted 5-organostibano-1H-1,2,3-triazoles (3a–f) were synthesized by the Cu-catalyzed azide-alkyne cycloaddition of various ethynylstibanes (1) with benzylazide (2) in the presence of CuBr (5 mol%) under aerobic conditions. The reaction of 5-stibanotriazoles with HCl afforded C5-unsubstituted 1,2,3-triazoles (4a–f). The antitumor activity of trisubstituted 5-organostibano-1H-1,2,3-triazoles (3a–f) and their 5-unsubstituted 1,2,3-triazoles (4a–f) were evaluated in several tumor cell lines. All 5-stibanotriazoles (3a–f) exerted an excellent antitumor activity. On the contrary, 5-unsubstituted 1,2,3-triazoles (4a–f) without a diphenylantimony group in the molecule exhibited very low antitumor activity compared with 5-stibanotriazoles (3a–f). In compounds of both the series, the substituted 4-butyl group appeared to decrease antitumor activity. However, results suggested that organometal (antimony) in the molecule was required for greater antitumor activity. In addition, all 5-stibanotriazoles (3a–f), but not all 5-unsubstituted 1,2,3-triazoles (4a–f), exhibited cytotoxicity in normal vascular endothelial cells derived from bovine aorta. Among the compounds (3b–e) that exhibited excellent antitumor activity, those with 4-methylphenyl (3b) and 1-cyclohexenyl (3e) showed relatively low cytotoxicity to vascular endothelial cells. Together, these results suggest that trisubstituted 5-organostibano-1H-1,2,3-triazoles, including compounds 3b and 3e, may serve as potential anticancer therapeutic drugs in the future.     

Difference in reactivity of triel halides EX3 towards ferrocene

A facile route to the Fe²⁺-arene complex [(C₆H₆)FeCp][AlBr₄] is the reaction of ferrocene with AlBr₃ in benzene. The structure of the Fe²⁺-arene complex [(C₆H₆)FeCp][AlBr₄] · C₆H₆ was found to be isomorphous with those of [FeCp₂][ECl₄] · C₆H₆ (E = Al, Ga). The crystal structures of the [FeCp₂][AlCl₄] · C₆H₆ (E = Al, Ga) presented here show structural features which are different from those of solvent-free ferrocenium salts [FeCp₂][ECl₄] (E = Al, Ga, Fe). However, the cell parameters of solvent-free ferrocenium tetrafluoroborate [FeCp₂][BF₄] are also quite different from those of solvent-free [FeCp₂][ECl₄] (E = Al, Ga, Fe). In contrast to the eclipsed conformation in solvent-free [FeCp₂][ECl₄] (E = Al, Ga, Fe) the cyclopentadiene rings in [FeCp₂][BF₄] and [FeCp₂][ECl₄] · C₆H₆ (E = Al, Ga) are in a staggered conformation.     

Synthesis and characterization of silver(I) derivatives containing acylpyrazolonate and phosphino ligands: X-ray crystal structures of monomeric [Ag(Q)(PPh3)2] and of dimeric [{Ag(Q)(PiBu3)}2] (Q = 1-phenyl-3-methyl-4-tert-butylacetylpyrazolon-5-ato)

New silver(I) acylpyrazolonate derivatives [Ag(Q)], [Ag(Q)(PR₃)]₂ and [Ag(Q)(PR₃)₂] (HQ = 1-R¹-3-methyl-4-R²(CO)pyrazol-5-one, HQ^Bn = R¹ = C₆H₅, R² = CH₂C₆H₅; HQ^CHPh2 = R¹ = C₆H₅, R² = CH(C₆H₅)₂; HQ^nPe = R¹ = C₆H₅, R² = CH₂C(CH₃)₃; HQ^tBu = R¹ = C₆H₅, R² = C(CH₃)₃; HQ^fMe = R¹ = C₆H₄-p-CF₃, R² = CF₃; HQ^fEt = R¹ = C₆H₅, R² = CF₂CF₃; R = Ph or iBu) have been synthesized and characterized in the solid state and solution. The crystal structure of 1-(4-trifluoromethylphenyl)-3-methyl-5-pyrazolone, the precursor of proligand HQ^fMe and of derivatives [Ag(Q^nPe)(PPh₃)₂] and [Ag(Q^nPe)(PiBu₃)]₂ have been investigated. [Ag(Q^nPe)(PPh₃)₂] is a mononuclear compound with a silver atom in a tetrahedrally distorted AgO₂P₂ environment, whereas [Ag(Q^nPe)(PiBu₃)]₂ is a dinuclear compound with two O₂N-exotridentate bridging acylpyrazolonate ligands connecting both silver atoms, their coordination environment being completed by a phosphine ligand.